Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up

International Braz J Urol

Volumn 37, Issue 2, 2011, Pages 213-221

  El Fegoun, Amine B ^a   Barret, Eric ^a   Prapotnich, Dominique ^a   Soon, Shawn ^a   Cathelineau, Xavier ^a   Rozet, François ^a   Galiano, Marc ^a   Sanchez Salas, Rafael ^a   Vallancien, Guy ^a  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

High intensity focused; Prostate neoplasms; Transrectal; Ultrasound

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; FEASIBILITY STUDY; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; PROSTATE TUMOR; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 79959292865     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382011000200008     Document Type: Article

References (36)

1. Bianco FJ Jr, Scardino PT, Eastham JA: Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (" trifecta"). Urology. 2005; 66(5 Suppl): 83-94.
2. Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ: Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol. 2004; 172: 910-4.
3. Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD: Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol. 2003; 21: 3318-27.
4. Scardino PT, Abenhaim LL: Focal therapy for prostate cancer: analysis by an international panel. Urology. 2008; 72(6 Suppl): S1-2.
5. Cooperberg MR, Broering JM, Kantoff PW, Carroll PR: Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007; 178: S14-9.
6. Gelet A, Chapelon JY, Bouvier R, Souchon R, Pangaud C, Abdelrahim AF, et al.: Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol. 1996; 29: 174-83.
7. Blana A, Murat FJ, Walter B, Thuroff S, Wieland WF, Chaussy C, et al.: First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol. 2008; 53: 1194-201.
8. Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F: Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol. 2004; 171: 2265-7.
9. Thüroff S, Chaussy C, Vallancien G, Wieland W, Kiel HJ, Le Duc A, et al.: High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol. 2003; 17: 673-7.
10. de Senneville BD, Mougenot C, Moonen CT: Real-time adaptive methods for treatment of mobile organs by MRI-controlled high-intensity focused ultrasound. Magn Reson Med. 2007; 57: 319-30.
11. Blana A, Rogenhofer S, Ganzer R, Wild PJ, Wieland WF, Walter B: Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer. World J Urol. 2006; 24: 585-90.
12. Pasticier G, Chapet O, Badet L, Ardiet JM, Poissonnier L, Murat FJ, et al.: Salvage radiotherapy after high-intensity focused ultrasound for localized prostate cancer: early clinical results. Urology. 2008; 72: 1305-9.
13. Poissonnier L, Chapelon JY, Rouvière O, Curiel L, Bouvier R, Martin X, et al.: Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol. 2007; 51: 381-7.
14. Liatsikos E, Bynens B, Rabenalt R, Kallidonis P, Do M, Stolzenburg JU: Treatment of patients after failed high intensity focused ultrasound and radiotherapy for localized prostate cancer: salvage laparoscopic extraperitoneal radical prostatectomy. J Endourol. 2008; 22: 2295-8.
15. Korfage IJ, Essink-Bot ML, Borsboom GJ, Madalinska JB, Kirkels WJ, Habbema JD, et al.: Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer. 2005; 116: 291-6.
16. Dearnaley DP, Sydes MR, Graham JD, Aird EG, Bottomley D, Cowan RA, et al.: Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2007; 8: 475-87.
17. Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, et al.: Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004; 96: 1358-67.
18. Widmark A, Fransson P, Tavelin B: Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer. 1994; 74: 2520-32.
19. Ahmed HU, Zacharakis E, Dudderidge T, Armitage JN, Scott R, Calleary J, et al.: High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series. Br J Cancer. 2009; 101: 19-26.
20. Muto S, Yoshii T, Saito K, Kamiyama Y, Ide H, Horie S: Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol. 2008; 38: 192-9.
21. Klotz L: Active surveillance with selective delayed intervention: using natural history to guide treatment in good risk prostate cancer. J Urol. 2004; 172: S48-50; discussion S50-1.
22. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR: The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol. 2004; 22: 2141-9.
23. Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, et al.: Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol. 2007; 178: 2260-7.
24. Pelzer A, Bektic J, Berger AP, Pallwein L, Halpern EJ, Horninger W, et al.: Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/mL using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol. 2005; 173: 1926-9.
25. Puech P, Huglo D, Petyt G, Lemaitre L, Villers A: Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography. Curr Opin Urol. 2009; 19: 168-76.
26. Chon CH, Lai FC, McNeal JE, Presti JC Jr: Use of extended systematic sampling in patients with a prior negative prostate needle biopsy. J Urol. 2002; 167: 2457-60.
27. Moran BJ, Braccioforte MH, Conterato DJ: Re-biopsy of the prostate using a stereotactic transperineal technique. J Urol. 2006; 176: 1376-81; discussion 1381.
28. Tareen B, Godoy G, Sankin A, Temkin S, Lepor H, Taneja SS: Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int. 2009; 104: 195-9.
29. Wise AM, Stamey TA, McNeal JE, Clayton JL: Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology. 2002; 60: 264-9.
30. Villers A, McNeal JE, Freiha FS, Stamey TA: Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer. 1992; 70: 2313-8.
31. Prando A: Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging. Int Braz J Urol. 2010; 36: 100-1.
32. DiBlasio CJ, Derweesh IH, Malcolm JB, Maddox MM, Aleman MA, Wake RW: Contemporary analysis of erectile, voiding, and oncologic outcomes following primary targeted cryoablation of the prostate for clinically localized prostate cancer. Int Braz J Urol. 2008; 34: 443-50.
33. Barua J, Campbell I I, Cole O, Harris D, Kaisary A, Larner T, et al.: High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up. BJU Int. 2009; 104: 1794; authors reply 1794-5.
34. Abdel-Wahab M, Pollack A: Prostate cancer: Defining biochemical failure in patients treated with HIFU. Nat Rev Urol. 2010; 7: 186-7.
35. Berge V, Baco E, Karlsen SJ: A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: Early results. Scand J Urol Nephrol. 2010; 44: 223-7.
36. Uchida T, Shoji S, Nakano M, Hongo S, Nitta M, Murota A, et al.: Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience. Int J Urol. 2009; 16: 881-6.